Details of the Drug Formulations | DrugMAP

General Information of Drug (ID: DMT81LZ)

Drug Name

ARN-509 Drug Info

Synonyms

Arn-509 (AR inhibitor)

Indication

Disease Entry	ICD 11	Status	REF
Acute myeloid leukaemia	2A60	Approved	[1]
Prostate cancer	2C82.0	Phase 3	[2]

Cross-matching ID

PubChem CID: 24872560
CAS Number: 956104-40-8
TTD ID: D0S7LG
INTEDE ID: DR0121
ACDINA ID: D00840

Full List of Drug Formulations Containing This Drug

Apalutamide 60 mg tablet

Company	Formulation ID	FDA Description
Janssen Products	F23073	Colloidal Anhydrous Silica; Croscarmellose Sodium; Hydroxypropyl Methylcellulose-Acetate Succinate; Magnesium Stearate; Microcrystalline Cellulose; Silicified Microcrystalline Cellulose; Iron Oxide Black; Iron Oxide Yellow; Polyethylene Glycol; Polyvinyl Alcohol; Talc; Titanium Dioxide
------------------------------------------------------------------------------------

References

1	2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
2	ClinicalTrials.gov (NCT01946204) A Study of ARN-509 in Men With Non-Metastatic Castration-Resistant Prostate Cancer. U.S. National Institutes of Health.